Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bioequivalence Study of Fluticasone Furoate Nasal Spray in Seasonal Allergic Rhinitis
NCT01279057Phase 3Completed
- Sponsor
- Sandoz
- Start
- Dec 2010
- Primary completion
- Feb 2011
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 3 trial of fluticasone in seasonal allergic rhinitis (SAR), sponsored by Sandoz. Started Dec 2010; status: completed.
02
Drugs
fluticasone
03
Conditions
seasonal allergic rhinitis (SAR)
Beyond the preview
Go deeper on NCT01279057.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01279057.